Showing results (131-140 of 170) with videos related to
Sort By:
Pageof 17
Cancer|November 1, 1987
Combination hormone therapy for metastatic breast cancer. An ECOG study of megestrol and aminoglutethimideJ Horton, M Knuiman, A M Keller, et al.Cancer Chemotherapy Reports|July 1, 1975
Potential biologic markers in Burkitt's lymphomaT P Waalkes, C W Gehrke, W A Bleyer, et al.Journal of the National Cancer Institute. Monographs|January 1, 1992
Chemotherapy versus observation in high-risk node-negative breast cancer patientsE G Mansour, L Eudey, D C Tormey, et al.The New England Journal of Medicine|February 23, 1989
Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup studyE G Mansour, R Gray, A H Shatila, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1987
Platinum analogue combination chemotherapy: cisplatin and carboplatin--a phase I trial with pharmacokinetic assessment of the effect of cisplatin administration on carboplatin excretionD L Trump, J L Grem, K D Tutsch, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1989
Myelodysplastic syndrome and acute nonlymphocytic leukemia secondary to mitolactol treatment in patients with breast cancerG Falkson, R S Gelman, R Dreicer, et al.Investigational New Drugs|January 1, 1995
A phase II study of interleukin-2 with and without beta-interferon in the treatment of advanced renal cell carcinomaR S Witte, T Leong, M S Ernstoff, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1984
Aggressive combined modality therapy for advanced local-regional breast carcinomaC L Loprinzi, P P Carbone, D C Tormey, et al.American Journal of Clinical Oncology|February 1, 1991
A pilot study of three sequential chemotherapeutic regimens in metastatic breast cancerD T Ransom, D Neuberg, C L Loprinzi, et al.Cancer Treatment Reports|October 1, 1987
Actual versus ideal weight in the calculation of surface area: effects on dose of 11 chemotherapy agentsR S Gelman, D C Tormey, R Betensky, et al.Pageof 17